Shuttle Pharmaceuticals Ownership 2024 | Who Owns Shuttle Pharmaceuticals Now?

Overview RevenueFinancials Chart

Institutional Ownership

0.52%

Insider Ownership

45.80%

Retail Ownership

53.68%

Institutional Holders

6.00

Shuttle Pharmaceuticals Institutional Shareholders

Institutional Shareholders by % of Total Shares

Name	% Total Shares	% Total Assets	Current Shares	Change Amount	Change %	Market Value	Date
TWO SIGMA SECURITIES, LLC	0.26%	0.00%	42,288	42,288	100.00%	16,907	Jun 30, 2024
GEODE CAPITAL MANAGEMENT, LLC	0.19%	-	30,823	-6,134	-16.60%	12,297	Jun 30, 2024
VIRTU FINANCIAL LLC	0.08%	0.00%	12,744	2,266	21.63%	5,000	Jun 30, 2024
FEDERATION DES CAISSES DESJARDINS DU QUEBEC	0.00%	-	500	-	-	200	Jun 30, 2024
TOWER RESEARCH CAPITAL LLC (TRC)	0.00%	-	431	180	71.71%	172	Jun 30, 2024
BANK OF AMERICA CORP /DE/	0.00%	-	56	56	100.00%	22	Jun 30, 2024
WELLS FARGO & COMPANY/MN	-	-	-	-54	-100.00%	-	Jun 30, 2024
RENAISSANCE TECHNOLOGIES LLC	-	-	-	-16,500	-100.00%	-	Jun 30, 2024
UBS GROUP AG	-	-	-	-1,121	-100.00%	-	Jun 30, 2024

Shuttle Pharmaceuticals's largest institutional shareholder is TWO SIGMA SECURITIES, LLC, holding 0.26% of the company's total share outstanding, currently valued at $16.91K. The top 10 institutional shareholders own together 0.52% of the company.

Institutional Shareholders by % of Total Assets

Name	% Total Shares	% Total Assets	Current Shares	Change Amount	Change %	Market Value	Date
VIRTU FINANCIAL LLC	0.08%	0.00%	12,744	2,266	21.63%	5,000	Jun 30, 2024
TWO SIGMA SECURITIES, LLC	0.26%	0.00%	42,288	42,288	100.00%	16,907	Jun 30, 2024
TOWER RESEARCH CAPITAL LLC (TRC)	0.00%	-	431	180	71.71%	172	Jun 30, 2024
GEODE CAPITAL MANAGEMENT, LLC	0.19%	-	30,823	-6,134	-16.60%	12,297	Jun 30, 2024
FEDERATION DES CAISSES DESJARDINS DU QUEBEC	0.00%	-	500	-	-	200	Jun 30, 2024
BANK OF AMERICA CORP /DE/	0.00%	-	56	56	100.00%	22	Jun 30, 2024
WELLS FARGO & COMPANY/MN	-	-	-	-54	-100.00%	-	Jun 30, 2024
RENAISSANCE TECHNOLOGIES LLC	-	-	-	-16,500	-100.00%	-	Jun 30, 2024
UBS GROUP AG	-	-	-	-1,121	-100.00%	-	Jun 30, 2024

The largest Shuttle Pharmaceuticals shareholder by % of total assets is VIRTU FINANCIAL LLC. The company owns 12.74K shares of Shuttle Pharmaceuticals (SHPH), representing 0.00% of its total assets.

Institutional Buyers

Name	% Total Shares	% Total Assets	Current Shares	Change Amount	Change %	Market Value	Date
TWO SIGMA SECURITIES, LLC	0.26%	0.00%	42,288	42,288	100.00%	16,907	Jun 30, 2024
VIRTU FINANCIAL LLC	0.08%	0.00%	12,744	2,266	21.63%	5,000	Jun 30, 2024
TOWER RESEARCH CAPITAL LLC (TRC)	0.00%	-	431	180	71.71%	172	Jun 30, 2024
BANK OF AMERICA CORP /DE/	0.00%	-	56	56	100.00%	22	Jun 30, 2024
FEDERATION DES CAISSES DESJARDINS DU QUEBEC	0.00%	-	500	-	-	200	Jun 30, 2024
WELLS FARGO & COMPANY/MN	-	-	-	-54	-100.00%	-	Jun 30, 2024
UBS GROUP AG	-	-	-	-1,121	-100.00%	-	Jun 30, 2024
GEODE CAPITAL MANAGEMENT, LLC	0.19%	-	30,823	-6,134	-16.60%	12,297	Jun 30, 2024
RENAISSANCE TECHNOLOGIES LLC	-	-	-	-16,500	-100.00%	-	Jun 30, 2024

As of Jun 30 2024, Shuttle Pharmaceuticals's largest institutional buyer is TWO SIGMA SECURITIES, LLC. The company purchased 42.29K stocks of SHPH, valued at $16.91K.

Institutional Sellers

Name	% Total Shares	% Total Assets	Current Shares	Change Amount	Change %	Market Value	Date
RENAISSANCE TECHNOLOGIES LLC	-	-	-	-16,500	-100.00%	-	Jun 30, 2024
GEODE CAPITAL MANAGEMENT, LLC	0.19%	-	30,823	-6,134	-16.60%	12,297	Jun 30, 2024
UBS GROUP AG	-	-	-	-1,121	-100.00%	-	Jun 30, 2024
WELLS FARGO & COMPANY/MN	-	-	-	-54	-100.00%	-	Jun 30, 2024
FEDERATION DES CAISSES DESJARDINS DU QUEBEC	0.00%	-	500	-	-	200	Jun 30, 2024
BANK OF AMERICA CORP /DE/	0.00%	-	56	56	100.00%	22	Jun 30, 2024
TOWER RESEARCH CAPITAL LLC (TRC)	0.00%	-	431	180	71.71%	172	Jun 30, 2024
VIRTU FINANCIAL LLC	0.08%	0.00%	12,744	2,266	21.63%	5,000	Jun 30, 2024
TWO SIGMA SECURITIES, LLC	0.26%	0.00%	42,288	42,288	100.00%	16,907	Jun 30, 2024

As of Jun 30 2024, Shuttle Pharmaceuticals's biggest institutional seller is RENAISSANCE TECHNOLOGIES LLC. The company sold -16.50K shares of SHPH, valued at -.

Institutional New positions

Name	% Total Shares	% Total Assets	Current Shares	Change Amount	Change %	Market Value	Date
TWO SIGMA SECURITIES, LLC	0.26%	0.00%	42,288	42,288	100.00%	16,907	Jun 30, 2024
BANK OF AMERICA CORP /DE/	0.00%	-	56	56	100.00%	22	Jun 30, 2024

Shuttle Pharmaceuticals's largest new institutional shareholder by number of shares is TWO SIGMA SECURITIES, LLC, purchased 42.29K shares, valued at $16.91K, as of undefined.

Institutional Sold Out

Name	% Total Shares	% Total Assets	Current Shares	Change Amount	Change %	Market Value	Date
RENAISSANCE TECHNOLOGIES LLC	-	-	-	-16,500	-100.00%	-	Jun 30, 2024
UBS GROUP AG	-	-	-	-1,121	-100.00%	-	Jun 30, 2024
WELLS FARGO & COMPANY/MN	-	-	-	-54	-100.00%	-	Jun 30, 2024

Shuttle Pharmaceuticals's largest sold out institutional shareholder by shares sold is RENAISSANCE TECHNOLOGIES LLC, sold -16.50K shares, valued at -, as of undefined.

Shuttle Pharmaceuticals Mutual Fund Holders

Name	% Total Assets	Total Shares	Change Amount	Change %	Date
FIDELITY CONCORD STREET TRUST	0.00%	36,957	-	-	Feb 29, 2024
USAA MUTUAL FUNDS TRUST	0.00%	572	-	-	Jan 31, 2024
BLACKROCK FUNDS	0.00%	4,125	-	-	Mar 28, 2024

Shuttle Pharmaceuticals's largest mutual fund holder by % of total assets is "FIDELITY CONCORD STREET TRUST", owning 36.96K shares, compromising 0.00% of its total assets.

Shuttle Pharmaceuticals Institutional Ownership Trends

Institutional Holdings Trend

Date	Holdings	Change %
30 Jun, 24	6	-14.29%
31 Mar, 24	7	16.67%
31 Dec, 23	6	50.00%
30 Sep, 23	4	300.00%
30 Jun, 23	1	-50.00%
31 Mar, 23	2	-75.00%
31 Dec, 22	8	-11.11%
30 Sep, 22	9	-

As of 30 Jun 24, 6 institutions are holding Shuttle Pharmaceuticals's shares, representing a decrease of -14.29% compared to the previous quarter.

Shares Outstanding Trend

Date	Shares Outstanding	Change %
30 Jun, 24	86,842	31.86%
31 Mar, 24	65,861	-51.48%
31 Dec, 23	135,747	-47.29%
30 Sep, 23	257,532	2.64%
30 Jun, 23	250,915	608.32%
31 Mar, 23	35,424	-73.48%
31 Dec, 22	133,596	-73.49%
30 Sep, 22	503,901	-

Shuttle Pharmaceuticals (SHPH) has 86.84K shares outstanding as of 30 Jun 24, up 31.86% compared to the previous quarter.

Institutional Ownership Trend

Date	Ownership %	Change %
30 Jun, 24	0.52%	268.92%
31 Mar, 24	0.44%	59.38%
31 Dec, 23	0.86%	26.44%
30 Sep, 23	1.81%	53.33%
30 Jun, 23	1.84%	2726.40%
31 Mar, 23	0.26%	15.60%
31 Dec, 22	1.29%	5.25%
30 Sep, 22	4.96%	-

As of 30 Jun 24, Shuttle Pharmaceuticals is held by 0.52% institutional shareholders, representing a 268.92% growth compared to 31 Mar 24.

Institutional Increased Positions Trend

Date	Increased Positions	Change %
30 Jun, 24	4	-
31 Mar, 24	4	-
31 Dec, 23	4	33.33%
30 Sep, 23	3	200.00%
30 Jun, 23	1	-
31 Mar, 23	-	-100.00%
31 Dec, 22	3	-66.67%
30 Sep, 22	9	-

4 institutional shareholders have increased their position in SHPH stock as of 30 Jun 24 compared to 4 in the previous quarter (a 0.00% increase).

Institutional Reduced Positions Trend

Date	Reduced Positions	Change %
30 Jun, 24	1	-50.00%
31 Mar, 24	2	100.00%
31 Dec, 23	1	-
30 Sep, 23	1	-
30 Jun, 23	-	-100.00%
31 Mar, 23	2	-50.00%
31 Dec, 22	4	-
30 Sep, 22	-	-

1 institutional shareholders have reduced their position in SHPH stock as of 30 Jun 24 compared to 2 in the previous quarter (a -50.00% decrease).

All Institutional Ownership Trend Data

Date	Holdings	Change %	Shares Outstanding	Change %	Ownership %	Change %	Increased Positions	Change %	Reduced Positions	Change %
30 Jun, 24	6	-14.29%	86,842	31.86%	0.52%	268.92%	4	-	1	-50.00%
31 Mar, 24	7	16.67%	65,861	-51.48%	0.44%	59.38%	4	-	2	100.00%
31 Dec, 23	6	50.00%	135,747	-47.29%	0.86%	26.44%	4	33.33%	1	-
30 Sep, 23	4	300.00%	257,532	2.64%	1.81%	53.33%	3	200.00%	1	-
30 Jun, 23	1	-50.00%	250,915	608.32%	1.84%	2726.40%	1	-	-	-100.00%
31 Mar, 23	2	-75.00%	35,424	-73.48%	0.26%	15.60%	-	-100.00%	2	-50.00%
31 Dec, 22	8	-11.11%	133,596	-73.49%	1.29%	5.25%	3	-66.67%	4	-
30 Sep, 22	9	-	503,901	-	4.96%	-	9	-	-	-

Shuttle Pharmaceuticals Insider Shareholders Trades

Open Market Insider Trades

Date	Name	Relation	Role	Transaction	Buy/Sell	Shares	Price	Value	Shares Held
Mar 14, 2024	Senanayake Chris	director	-	S-Sale	Sell	1,626	$1.60	$2.61K	2,791
Jan 02, 2024	Brown Milton	director	-	S-Sale	Sell	2,921	$0.46	$1.35K	1,094,610
Dec 20, 2023	Jacobs Bette	director	-	S-Sale	Sell	4,157	$0.46	$1.93K	27,064
Jan 09, 2023	Richards Steven M	director	-	S-Sale	Sell	995	$1.60	$1.60K	1,707
Jan 04, 2023	Adkins William	director	-	S-Sale	Sell	995	$1.60	$1.60K	184,071
Jan 04, 2023	Brown Milton	director	-	S-Sale	Sell	995	$1.60	$1.60K	1,072,531
Jan 03, 2023	Dritschilo Anatoly	officer	CEO and Chairman	S-Sale	Sell	8,372	$1.60	$13.44K	1,085,200
Jan 03, 2023	Rich Tyvin	officer	Chief Medical Officer	S-Sale	Sell	1,414	$1.60	$2.27K	2,429
Jan 03, 2023	Jung Mira	officer	Chief Scientific Officer	S-Sale	Sell	328	$1.60	$526.44	1,071,388
Jan 03, 2023	Jacobs Bette	director	-	S-Sale	Sell	4,366	$1.60	$7.01K	31,221
Dec 30, 2022	Dritschilo Peter	officer	President and COO	S-Sale	Sell	3,820	$1.60	$6.13K	6,560
Dec 30, 2022	Vander Hoek Michael	officer	Chief Financial Officer	S-Sale	Sell	2,243	$1.60	$3.60K	3,852

Open Market Insider Buys

Date	Name	Relation	Role	Transaction	Buy/Sell	Shares	Price	Value	Shares Held	Source

Insider Sells

Date	Name	Relation	Role	Transaction	Buy/Sell	Shares	Price	Value	Shares Held
Jun 25, 2024	Lorber Timothy J.	officer	Chief Financial Officer		Sell	-	-	-	227,635
Mar 14, 2024	Senanayake Chris	director	-	S-Sale	Sell	1,626	$1.60	$2.61K	2,791
Jan 02, 2024	Brown Milton	director	-	S-Sale	Sell	2,921	$0.46	$1.35K	1,094,610
Dec 20, 2023	Jacobs Bette	director	-	S-Sale	Sell	4,157	$0.46	$1.93K	27,064
Aug 18, 2023	Dritschilo Anatoly	director, 10 percent owner, officer	CEO and Chairman	G-Gift	Sell	2,100,000	-	-	1,104,407
Jan 09, 2023	Richards Steven M	director	-	S-Sale	Sell	995	$1.60	$1.60K	1,707
Jan 04, 2023	Adkins William	director	-	S-Sale	Sell	995	$1.60	$1.60K	184,071
Jan 04, 2023	Brown Milton	director	-	S-Sale	Sell	995	$1.60	$1.60K	1,072,531
Jan 03, 2023	Dritschilo Anatoly	officer	CEO and Chairman	S-Sale	Sell	8,372	$1.60	$13.44K	1,085,200
Jan 03, 2023	Rich Tyvin	officer	Chief Medical Officer	S-Sale	Sell	1,414	$1.60	$2.27K	2,429
Jan 03, 2023	Jung Mira	officer	Chief Scientific Officer	S-Sale	Sell	328	$1.60	$526.44	1,071,388
Jan 03, 2023	Jacobs Bette	director	-	S-Sale	Sell	4,366	$1.60	$7.01K	31,221
Dec 30, 2022	Dritschilo Peter	officer	President and COO	S-Sale	Sell	3,820	$1.60	$6.13K	6,560
Dec 30, 2022	Vander Hoek Michael	officer	Chief Financial Officer	S-Sale	Sell	2,243	$1.60	$3.60K	3,852
Nov 09, 2022	Jacobs Bette	director	-		Sell	-	-	-	35,587
Sep 09, 2022	Brown Milton	director	-		Sell	-	-	-	1,073,526

All Insider Owners Trades

Date	Name	Relation	Role	Transaction	Buy/Sell	Shares	Price	Value	Shares Held
Jun 25, 2024	Lorber Timothy J.	officer	Chief Financial Officer		Sell	-	-	-	227,635
Mar 14, 2024	Senanayake Chris	director	-	S-Sale	Sell	1,626	$1.60	$2.61K	2,791
Mar 08, 2024	Vander Hoek Michael	officer	Chief Financial Officer	A-Award	Buy	100,000	-	-	103,852
Jan 02, 2024	Brown Milton	director	-	S-Sale	Sell	2,921	$0.46	$1.35K	1,094,610
Dec 20, 2023	Jacobs Bette	director	-	S-Sale	Sell	4,157	$0.46	$1.93K	27,064
Aug 18, 2023	Dritschilo Anatoly	director, 10 percent owner, officer	CEO and Chairman	G-Gift	Buy	2,100,000	-	-	2,100,000
Aug 18, 2023	Dritschilo Anatoly	director, 10 percent owner, officer	CEO and Chairman	G-Gift	Sell	2,100,000	-	-	1,104,407
Feb 17, 2023	Brown Milton	director	-	A-Award	Buy	25,000	$1.92	$48.00K	25,000
Jan 09, 2023	Richards Steven M	director	-	S-Sale	Sell	995	$1.60	$1.60K	1,707
Jan 04, 2023	Adkins William	director	-	S-Sale	Sell	995	$1.60	$1.60K	184,071
Jan 04, 2023	Adkins William	director	-	J-Other	Buy	138,889	-	-	138,889
Jan 04, 2023	Brown Milton	director	-	S-Sale	Sell	995	$1.60	$1.60K	1,072,531
Jan 03, 2023	Dritschilo Anatoly	officer	CEO and Chairman	S-Sale	Sell	8,372	$1.60	$13.44K	1,085,200
Jan 03, 2023	Rich Tyvin	officer	Chief Medical Officer	S-Sale	Sell	1,414	$1.60	$2.27K	2,429
Jan 03, 2023	Jung Mira	officer	Chief Scientific Officer	S-Sale	Sell	328	$1.60	$526.44	1,071,388
Jan 03, 2023	Jacobs Bette	director	-	S-Sale	Sell	4,366	$1.60	$7.01K	31,221
Dec 30, 2022	Dritschilo Peter	officer	President and COO	S-Sale	Sell	3,820	$1.60	$6.13K	6,560
Dec 30, 2022	Vander Hoek Michael	officer	Chief Financial Officer	S-Sale	Sell	2,243	$1.60	$3.60K	3,852
Nov 09, 2022	Jacobs Bette	director	-		Sell	-	-	-	35,587
Sep 09, 2022	Brown Milton	director	-		Sell	-	-	-	1,073,526

The last insider sell of Shuttle Pharmaceuticals's stock was made by Lorber Timothy J. on Jun 25 2024, selling - shares at - per share (valued at -).

Shuttle Pharmaceuticals Insider Ownership Trends

All Insider Trades Trend

Date	Buy	Sell	Buy/Sell Ratio
Q1 2024	1	-	-
Q4 2023	-	2	-
Q3 2023	1	1	100.00%
Q1 2023	1	-	-
Q4 2022	-	10	-
Q3 2022	1	11	9.09%

1 total buy trades, and 0 total sell trades (buy/sell ratio of 0%) were made by Shuttle Pharmaceuticals's insiders, as of Q1 2024.

Open Market Insider Trades Trend

Date	Buy	Sell	Buy/Sell Ratio
Q1 2024	-	-	-
Q4 2023	-	2	-
Q3 2023	-	-	-
Q1 2023	-	-	-
Q4 2022	-	9	-
Q3 2022	-	-	-

As of Q1 2024, Insider owners conducted 0 open market buy trades and 0 open market sell trades of Shuttle Pharmaceuticals's stocks.

Shuttle Pharmaceuticals Peer Ownership

Ticker	Company
AKAN	Akanda Corp.
TLRY	Tilray Brands, Inc.
LFCR	Lifecore Biomedical, Inc.
ORGO	Organogenesis Holdings Inc.
ALIM	Alimera Sciences, Inc.
DERM	Journey Medical Corporation
LSDI	Lucy Scientific Discovery Inc.
AGRX	Agile Therapeutics, Inc.
CTLT	Catalent, Inc.

SHPH Ownership FAQ

Who Owns Shuttle Pharmaceuticals?

Shuttle Pharmaceuticals is owned by institutional shareholders (0.52%), insiders (45.80%), and public (53.68%). The largest institutional shareholder of Shuttle Pharmaceuticals is TWO SIGMA SECURITIES, LLC (0.26% of total shares) and the top mutual fund owner is FIDELITY CONCORD STREET TRUST (0.00% of total shares).

Who are the major institutional shareholders of Shuttle Pharmaceuticals?

Shuttle Pharmaceuticals's major institutional shareholders are TWO SIGMA SECURITIES, LLC, GEODE CAPITAL MANAGEMENT, LLC, VIRTU FINANCIAL LLC, FEDERATION DES CAISSES DESJARDINS DU QUEBEC, and TOWER RESEARCH CAPITAL LLC (TRC). The top five shareholders own together 0.52% of the company's share outstanding.

How many Shuttle Pharmaceuticals shareholders are there?

As of Jun 2024, there are 6 institutional shareholders of Shuttle Pharmaceuticals.

What percentage of Shuttle Pharmaceuticals is owned by TWO SIGMA SECURITIES, LLC?

TWO SIGMA SECURITIES, LLC owns 42.29K shares of Shuttle Pharmaceuticals, representing 0.26% of the company's total shares outstanding, valued at $16.91K (as of Jun 2024).

What percentage of Shuttle Pharmaceuticals is owned by GEODE CAPITAL MANAGEMENT, LLC?

As of Jun 2024, GEODE CAPITAL MANAGEMENT, LLC holds 30.82K shares of Shuttle Pharmaceuticals (SHPH), compromising 0.19% of the company, valued at $12.3K.

What percentage of Shuttle Pharmaceuticals is owned by VIRTU FINANCIAL LLC?

VIRTU FINANCIAL LLC is the third largest holder of Shuttle Pharmaceuticals. The company owns 12.74K of the company's shares outstanding (worth $5K).